Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aspen Aerogels (ASPN) EBITDA (2016 - 2025)

Historic EBITDA for Aspen Aerogels (ASPN) over the last 13 years, with Q3 2025 value amounting to -$3.3 million.

  • Aspen Aerogels' EBITDA fell 11924.14% to -$3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$293.1 million, marking a year-over-year decrease of 81139.67%. This contributed to the annual value of $54.5 million for FY2024, which is 21083.67% up from last year.
  • As of Q3 2025, Aspen Aerogels' EBITDA stood at -$3.3 million, which was down 11924.14% from -$5.2 million recorded in Q2 2025.
  • Aspen Aerogels' 5-year EBITDA high stood at $20.0 million for Q2 2024, and its period low was -$299.3 million during Q1 2025.
  • In the last 5 years, Aspen Aerogels' EBITDA had a median value of -$9.7 million in 2022 and averaged -$22.2 million.
  • As far as peak fluctuations go, Aspen Aerogels' EBITDA skyrocketed by 96384.67% in 2024, and later crashed by 1238821.84% in 2025.
  • Quarter analysis of 5 years shows Aspen Aerogels' EBITDA stood at -$16.3 million in 2021, then skyrocketed by 40.74% to -$9.7 million in 2022, then surged by 114.31% to $1.4 million in 2023, then skyrocketed by 963.85% to $14.7 million in 2024, then tumbled by 122.76% to -$3.3 million in 2025.
  • Its EBITDA stands at -$3.3 million for Q3 2025, versus -$5.2 million for Q2 2025 and -$299.3 million for Q1 2025.